# Loiasis Cross-reactive Antigenemia and Treatment-related Adverse Events

> **NCT05085665** · PHASE4 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 41 (actual)

## Conditions studied

- Loiasis

## Interventions

- **DRUG:** Ivermectin

## Key facts

- **NCT ID:** NCT05085665
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-30
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-09-30
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2022-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05085665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05085665, "Loiasis Cross-reactive Antigenemia and Treatment-related Adverse Events". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05085665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*